We are live on ! Find out more
Klingenstein Fields & Co

Klingenstein Fields & Co Portfolio holdings

AUM $2.84B Turnover 8.37%
1-Year Est. Return 23.18%
 

Klingenstein Fields & Co., which does business as Klingenstein Fields Advisors, is an independently owned wealth manager for high net worth individuals, families, foundations and nonprofits. Its roots lie in Wertheim & Company, a merchant bank started by Joseph Klingenstein and Maurice Wertheim, which later joined with Schroder as Wertheim Schroder. Frederick Klingenstein, who had led Wertheim's expansion into investment banking and investment management, left Wertheim Schroder with John Klingenstein and Ken Fields to form Klingenstein Fields. It provides wealth planning and investment management built around each client's goals.

This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+23.18%
3 Year Est. Return
+106.78%
5 Year Est. Return
+113.1%
10 Year Est. Return
+364.83%
AUM
$2.48B
AUM Growth
-$34.4M
Cap. Flow
-$68.7M
Cap. Flow %
-2.77%
Top 10 Hldgs %
37.3%
Holding
187
New
3
Increased
37
Reduced
75
Closed
7
Avg Time Held
7 years
Top 10 Avg Time Held
4 years
Top 20 Avg Time Held
4.5 years

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.23M
2
LLY icon
Eli Lilly
LLY
+$431K
3
ABT icon
Abbott
ABT
+$312K
4
EXEL icon
Exelixis
EXEL
+$227K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$226K

Sector Composition

Rank Sector Weight
1 Technology 26.97%
2 Financials 13.87%
3 Healthcare 11.95%
4 Communication Services 10.39%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AVGO icon
1
Broadcom
AVGO
$1.7T
$154M 6.22%
665,117
-45,826
-6% -$8.48M
2016 Q2
34 quarters
MSFT icon
2
Microsoft
MSFT
$3.77T
$102M 4.11%
242,095
-1,794
-0.7% -$764K
2013 Q2
46 quarters
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.22T
$96.8M 3.9%
213,623
-1,607
-0.7% -$742K
2013 Q2
46 quarters
AAPL icon
4
Apple
AAPL
$5.12T
$95.9M 3.87%
383,031
-4,579
-1% -$1.08M
2013 Q2
46 quarters
AMZN icon
5
Amazon
AMZN
$2.89T
$88.1M 3.55%
401,507
-3,732
-0.9% -$764K
2013 Q2
46 quarters
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.48T
$87M 3.51%
459,582
-6,848
-1% -$1.2M
2015 Q4
36 quarters
PANW icon
7
Palo Alto Networks
PANW
$269B
$85.3M 3.44%
468,624
-7,508
-2% -$1.42M
2017 Q2
30 quarters
LLY icon
8
Eli Lilly
LLY
$1.23T
$79.4M 3.2%
102,797
+520
+0.5% +$431K
2013 Q2
46 quarters
DIS icon
9
Walt Disney
DIS
$212B
$70M 2.82%
628,202
-1,120
-0.2% -$118K
2013 Q2
46 quarters
PEP icon
10
PepsiCo
PEP
$193B
$66.7M 2.69%
438,790
-1,125
-0.3% -$184K
2013 Q2
46 quarters
UNP icon
11
Union Pacific
UNP
$179B
$62.7M 2.53%
274,775
-422
-0.2% -$100K
2013 Q2
46 quarters
NVDA icon
12
NVIDIA
NVDA
$3.64T
$56M 2.26%
416,830
+1,622
+0.4% +$224K
2022 Q3
9 quarters
COST icon
13
Costco
COST
$489B
$49.9M 2.01%
54,487
-658
-1% -$611K
2013 Q2
46 quarters
JPM icon
14
JPMorgan Chase
JPM
$863B
$49.7M 2%
207,251
-3,401
-2% -$792K
2013 Q2
46 quarters
GS icon
15
Goldman Sachs
GS
$252B
$49M 1.97%
85,560
-1,315
-2% -$733K
2016 Q4
32 quarters
ISRG icon
16
Intuitive Surgical
ISRG
$147B
$43.8M 1.77%
83,903
-1,142
-1% -$595K
2020 Q1
19 quarters
SPY icon
17
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$42.8M 1.72%
72,968
-3,125
-4% -$1.84M
2013 Q2
46 quarters
TMO icon
18
Thermo Fisher Scientific
TMO
$256B
$39.5M 1.59%
75,920
-395
-0.5% -$217K
2015 Q2
38 quarters
HON icon
19
Honeywell
HON
$71.2B
$38.8M 1.56%
182,217
-674
-0.4% -$141K
2013 Q2
46 quarters
GOOG icon
20
Alphabet (Google) Class C
GOOG
$3.45T
$38.8M 1.56%
203,688
-2,570
-1% -$454K
2013 Q2
46 quarters
RTX icon
21
RTX
RTX
$266B
$38.6M 1.56%
333,554
-1,961
-0.6% -$237K
2013 Q2
46 quarters
QQQ icon
22
Invesco QQQ Trust
QQQ
$452B
$37.3M 1.5%
73,018
-3,765
-5% -$1.9M
2013 Q2
46 quarters
NXPI icon
23
NXP Semiconductors
NXPI
$63.2B
$35.4M 1.43%
170,381
-1,376
-0.8% -$313K
2018 Q4
24 quarters
JNJ icon
24
Johnson & Johnson
JNJ
$658B
$35M 1.41%
242,200
-2,772
-1% -$430K
2013 Q2
46 quarters
NFLX icon
25
Netflix
NFLX
$246B
$34.7M 1.4%
389,550
-6,680
-2% -$550K
2019 Q1
23 quarters

Similar funds

Klingenstein Fields & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Klingenstein Fields & Co held 187 positions worth $2.48B, down 1.4% from $2.52B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q4 2024 filing shows 3 new, 37 increased, 75 reduced and 7 closed positions. Its largest new stake was Exelixis: 7,000 shares worth $233K. The largest sale was Schwab International Equity ETF, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Klingenstein Fields & Co's largest Q4 2024 buy was Exelixis: 7,000 shares worth $233K.
  • Klingenstein Fields & Co added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $5.23M increase.
  • Klingenstein Fields & Co's biggest Q4 2024 reduction was Schwab International Equity ETF, cutting an estimated $15.5M.
  • Klingenstein Fields & Co fully exited First Trust Long/Short Equity ETF in Q4 2024, selling an estimated $2.04M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.48B portfolio in Q4 2024.
  • Klingenstein Fields & Co opened 3 new positions and closed 7 in Q4 2024.
  • Klingenstein Fields & Co's portfolio value fell 1.4% quarter-over-quarter to $2.48B.

Based on Klingenstein Fields & Co's 13F filing for Q4 2024, filed 30 Jan 2025.